Design, synthesis and in vitro evaluation of coumarin–imidazo[1,2-a]pyridine derivatives against cancer induced osteoporosis
Author:
Affiliation:
1. Medicinal and Process Chemistry Division
2. CSIR-Central Drug Research Institute
3. Lucknow
4. India
5. Endocrinology Division
Abstract
The potential of coumarin–imidazo[1,2-a]pyridine hybrids to prevent bone loss in patients with bone metastases is discussed.
Publisher
Royal Society of Chemistry (RSC)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.rsc.org/en/content/articlepdf/2016/RA/C6RA15674F
Reference60 articles.
1. Inflammation, fracture and bone repair
2. http://www.iofbonehealth.org/facts-statistics
3. Discoveries, drugs and skeletal disorders
4. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
5. The Science and Practice of Bone Health in Oncology: Managing Bone Loss and Metastasis in Patients With Solid Tumors
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel 3-substituted coumarins inspire a custom pharmacology prediction pipeline: an anticancer discovery adventure;Future Medicinal Chemistry;2024-09-04
2. Insights into medicinal attributes of imidazo[1,2‐a]pyridine derivatives as anticancer agents;Archiv der Pharmazie;2024-09-02
3. The Groebke–Blackburn–Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019–2023);Beilstein Journal of Organic Chemistry;2024-08-01
4. Cu-catalysed diversity-oriented synthesis of isoxazole and imidazo[1,2-a]azine conjugates;Tetrahedron;2024-02
5. Latest developments in coumarin-based anticancer agents: mechanism of action and structure–activity relationship studies;RSC Medicinal Chemistry;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3